- Investing Ideas
- Japanese Pharmaceuticals & Biotech Top Stock Picks from Analysts
Japanese Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
13
Companies which are more than 50% undervalued based on analyst price target.
13 companies
Daiichi Sankyo Company
Market Cap: JP¥4.9t
Manufactures and sells pharmaceutical products in Japan and internationally.
4568
JP¥2,730.50
7D
3.1%
1Y
-16.2%
Sumitomo Pharma
Market Cap: JP¥628.0b
Manufactures, purchases, and sells pharmaceutical products for medical treatment in Japan, North America, and Asia.
4506
JP¥1,400.00
7D
-10.1%
1Y
38.2%
GNI Group
Market Cap: JP¥171.4b
Engages in the research, development, manufacturing, and sale of pharmaceuticals and biomaterials in Japan, China, and the United States.
2160
JP¥2,605.00
7D
-8.9%
1Y
-16.5%
PeptiDream
Market Cap: JP¥130.9b
A biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics.
4587
JP¥1,019.00
7D
-0.9%
1Y
-38.8%
Nxera Pharma
Market Cap: JP¥85.1b
Operates as a biopharmaceutical company, engages in drug discovery and development in Japan, the United States, Germany, Switzerland, Bermuda, the United Kingdom, and internationally.
4565
JP¥919.00
7D
-5.3%
1Y
4.2%
SanBio
Market Cap: JP¥77.2b
Engages in the development, production, and sale of regenerative cell medicines for the central nervous system in Japan and the United States.
4592
JP¥989.00
7D
-7.8%
1Y
-54.3%
Fuji Pharma
Market Cap: JP¥49.5b
Engages in the research and development, manufacture, and marketing of pharmaceutical products in Japan and internationally.
4554
JP¥1,894.00
7D
-5.3%
1Y
42.7%
Heartseed
Market Cap: JP¥36.8b
Develops and commercializes iPS cell-derived cardiomyocyte replacement therapy for heart failure.
219A
JP¥1,609.00
7D
-2.0%
1Y
-53.8%
Healios K.K
Market Cap: JP¥35.2b
Engages in the research, development, manufacturing, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States.
4593
JP¥261.00
7D
4.4%
1Y
-49.5%
StemRIM
Market Cap: JP¥19.8b
A biotechnology company, researches and develops regeneration-inducing medicine in Japan and internationally.
4599
JP¥316.00
7D
1.0%
1Y
3.6%
Kidswell Bio
Market Cap: JP¥7.4b
Develops pharmaceutical products for the treatment of pediatric, pediatric, intractable, and Asia-endemic diseases in Japan.
4584
JP¥150.00
7D
-3.8%
1Y
-40.2%
Noile-Immune Biotech
Market Cap: JP¥5.9b
Researches and develops CAR-T cells for novel cancer immunotherapies.
4893
JP¥136.00
7D
6.3%
1Y
-22.7%
TMS
Market Cap: JP¥4.7b
Engages in the research and development, manufacture, and sale of drug products, quasi-drugs, drug substances, medical devices, and medical commodities.
4891
JP¥104.00
7D
-3.7%
1Y
-41.2%